FFL
VRTX icon

Future Fund LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Future Fund LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5M Buy
5,037
+80
+2% +$35.5K 0.72% 58
2026
Q1 		$2.21M Buy
4,957
+154
+3% +$71.8K 0.78% 56
2025
Q4 		$2.18M Sell
4,803
-384
-7% -$166K 0.69% 42
2025
Q3 		$2.03M Buy
5,187
+1,184
+30% +$495K 0.72% 39
2025
Q2 		$1.78M Sell
4,003
-346
-8% -$159K 0.8% 30
2025
Q1 		$2.11M Buy
4,349
+2,297
+112% +$1.07M 2.71% 7
2024
Q4 		$826K Buy
2,052
+350
+21% +$162K 2.36% 22
2024
Q3 		$802K Sell
1,702
-482
-22% -$232K 2.32% 22
2024
Q2 		$1.03M Buy
2,184
+1,538
+238% +$668K 2.58% 18
2024
Q1 		$270K Sell
646
-314
-33% -$133K 2.19% 25
2023
Q4 		$391K Buy
+960
New +$355K 1.08% 10

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Future Fund LLC's VRTX Position: Q2 2026 in Review

Future Fund LLC increased its Vertex Pharmaceuticals (VRTX) stake by 1.6% in Q2 2026, buying an estimated $35.5K and bringing the position to 5,037 shares worth $2.5M. The position accounts for 0.72% of the portfolio, ranked #58.

Future Fund LLC first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. 1,756 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Future Fund LLC held 5,037 shares of Vertex Pharmaceuticals worth $2.5M as of Q2 2026.
  • Future Fund LLC bought 80 Vertex Pharmaceuticals shares in Q2 2026, an estimated $35.5K.
  • Vertex Pharmaceuticals made up 0.72% of Future Fund LLC's portfolio in Q2 2026, its #58 holding.
  • Future Fund LLC first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 1,756 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Future Fund LLC's 13F filing for Q2 2026, filed 12 Aug 2026.